Spruce Biosciences (SPRB) Short Interest Ratio & Short Volume → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free SPRB Stock Alerts $0.70 0.00 (-0.13%) (As of 03:21 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Spruce Biosciences Short Interest DataCurrent Short Volume164,000 sharesPrevious Short Volume320,400 sharesChange Vs. Previous Month-48.81%Dollar Volume Sold Short$115,734.80Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares41,150,000 sharesFloat Size22,160,000 sharesShort Percent of Float0.74%Today's Trading Volume141,263 sharesAverage Trading Volume1,094,754 sharesToday's Volume Vs. Average13% Short Selling Spruce Biosciences ? Sign up to receive the latest short interest report for Spruce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSPRB Short Interest Over TimeSPRB Days to Cover Over TimeSPRB Percentage of Float Shorted Over Time Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. Spruce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024164,000 shares $115,734.80 -48.8%0.7%0.1 $0.71 3/31/2024320,400 shares $251,802.36 +69.3%1.5%0.3 $0.79 3/15/2024189,300 shares $152,954.40 +461.7%N/A0.2 $0.81 2/29/202433,700 shares $168,500.00 -33.0%0.2%0.1 $5.00 2/15/202450,300 shares $254,518.00 +17.3%0.3%0.2 $5.06 1/31/202442,900 shares $157,014.00 +117.8%N/A0.2 $3.66 Get the Latest News and Ratings for SPRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202419,700 shares $48,856.00 -74.4%N/A0.1 $2.48 12/31/202377,000 shares $225,610.00 +64.5%N/A0.4 $2.93 12/15/202346,800 shares $77,688.00 -10.5%N/A0.3 $1.66 11/30/202352,300 shares $73,220.00 -24.0%N/A0.4 $1.40 11/15/202368,800 shares $79,120.00 +94.4%N/A0.6 $1.15 10/31/202335,400 shares $40,356.00 +49.4%N/A0.4 $1.14 10/15/202323,700 shares $37,683.00 -38.1%N/A0.3 $1.59 9/30/202338,300 shares $86,558.00 -53.4%N/A0.5 $2.26 9/15/202382,100 shares $201,966.00 +203.0%N/A1.1 $2.46 8/31/202327,100 shares $60,975.00 -14.0%N/A0.4 $2.25 8/15/202331,500 shares $68,040.00 -70.4%N/A0.3 $2.16 7/31/2023106,500 shares $239,625.00 +31.5%N/A0.8 $2.25 7/15/202381,000 shares $167,670.00 -16.3%N/A0.6 $2.07 6/30/202396,800 shares $208,120.00 +497.5%N/A0.6 $2.15 6/15/202316,200 shares $38,232.00 -96.6%N/A0.1 $2.36 5/31/2023470,900 shares $1.14 million -59.1%N/A2.9 $2.43 5/15/20231,150,000 shares $2.51 million -12.9%N/A6.6 $2.18 4/30/20231,320,000 shares $2.72 million -6.4%N/A7 $2.06 4/15/20231,410,000 shares $2.74 million +16.5%N/A6.5 $1.94 3/31/20231,210,000 shares $2.67 million +15.2%N/A2.6 $2.21 3/15/20231,050,000 shares $2.37 million -3.7%N/A0.7 $2.26 2/28/20231,090,000 shares $2.47 million +30.0%N/A0.7 $2.27 2/15/2023838,400 shares $2.29 million +1.6%13.6%0.6 $2.73 1/31/2023825,400 shares $2.43 million -31.8%6.8%0.6 $2.95 1/15/20231,210,000 shares $3.34 million +77.1%10.0%0.9 $2.76 12/30/2022683,100 shares $749,633.94 +16.1%5.6%0.5 $1.10 12/15/2022588,600 shares $588,600.00 +17.5%4.9%9.7 $1.00 11/30/2022500,900 shares $550,990.00 +52.3%4.1%9.3 $1.10 11/15/2022328,900 shares $345,345.00 +23.2%2.7%6.4 $1.05 10/31/2022267,000 shares $296,370.00 +211.9%2.2%7.9 $1.11 10/15/202285,600 shares $97,584.00 +40.1%0.7%2.6 $1.14 9/30/202261,100 shares $83,707.00 -19.5%0.5%2.2 $1.37 9/15/202275,900 shares $132,825.00 +22.0%0.6%1.7 $1.75 8/31/202262,200 shares $136,218.00 -13.6%0.5%1 $2.19Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. SPRB Short Interest - Frequently Asked Questions What is Spruce Biosciences' current short interest? Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 164,000 shares of SPRB short. 0.74% of Spruce Biosciences' shares are currently sold short. Learn More on Spruce Biosciences' current short interest. What is a good short interest percentage for Spruce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.74% of Spruce Biosciences' floating shares are currently sold short. Is Spruce Biosciences' short interest increasing or decreasing? Spruce Biosciences saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 164,000 shares, a decline of 48.8% from the previous total of 320,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Spruce Biosciences' float size? Spruce Biosciences currently has issued a total of 41,150,000 shares. Some of Spruce Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Spruce Biosciences currently has a public float of 22,160,000 shares. How does Spruce Biosciences' short interest compare to its competitors? 0.74% of Spruce Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Spruce Biosciences: Lexaria Bioscience Corp. (3.70%), Aprea Therapeutics, Inc. (2.01%), Daré Bioscience, Inc. (0.25%), NRx Pharmaceuticals, Inc. (6.69%), Acasti Pharma Inc. (0.06%), Forte Biosciences, Inc. (0.09%), Sol-Gel Technologies Ltd. (0.10%), Qilian International Holding Group Limited (0.78%), DURECT Co. (3.19%), Iterum Therapeutics plc (7.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Spruce Biosciences stock? Short selling SPRB is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRB shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spruce Biosciences? A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRB, which in turn drives the price of the stock up even further. How often is Spruce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Lexaria Bioscience Short Interest Data Aprea Therapeutics Short Interest Data Daré Bioscience Short Interest Data NRx Pharmaceuticals Short Interest Data Acasti Pharma Short Interest Data Forte Biosciences Short Interest Data Sol-Gel Technologies Short Interest Data Qilian International Holding Group Short Interest Data DURECT Short Interest Data Iterum Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold